Payment overview · 2025
General Payments
$68.90
3 reported records · 3 companies
Healthcare provider profile · identity verified
Gary Miller, MD
Allopathic & Osteopathic Physicians|Internal Medicine · CANTON, CT · NPI 1528027430
Verified facts
What the public records show
CMS Open Payments records show Gary Miller, MD received $68.90 in general payments during 2025 across 3 reported records.
HARMONY BIOSCIENCES LLC accounted for 45.2% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 2 associated products.
A separate comparison found the same explicitly named product in public Medicare Part D data: Rexulti.
AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported BRILINTA as an associated drug or biological on 993 records involving 512 distinct recipient NPIs. Public Medicare Part D data also shows 43 claims for Brilinta by this doctor in 2024.
AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported FARXIGA as an associated drug or biological on 106133 records involving 42906 distinct recipient NPIs. Public Medicare Part D data also shows 126 claims for Farxiga by this doctor in 2024.
AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported LOKELMA as an associated drug or biological on 6897 records involving 4326 distinct recipient NPIs. Public Medicare Part D data also shows 29 claims for Lokelma by this doctor in 2024.
AstraZeneca Pharmaceuticals LP reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported SYMBICORT as an associated drug or biological on 71 records involving 51 distinct recipient NPIs. Public Medicare Part D data also shows 15 claims for Symbicort by this doctor in 2024.
Otsuka America Pharmaceutical, Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported NUEDEXTA as an associated drug or biological on 393 records involving 285 distinct recipient NPIs. Public Medicare Part D data also shows 28 claims for Nuedexta by this doctor in 2024.
Otsuka America Pharmaceutical, Inc. reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported REXULTI as an associated drug or biological on 160756 records involving 46288 distinct recipient NPIs. Public Medicare Part D data also shows 44 claims for Rexulti by this doctor in 2024.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| HARMONY BIOSCIENCES LLC | Unresolved — no canonical attribution shown | $31.12 | 45.2% | 1 | 2025 |
| AstraZeneca Pharmaceuticals LP | Unresolved — no canonical attribution shown | $22.36 | 32.5% | 1 | 2025 |
| Otsuka America Pharmaceutical, Inc. | Unresolved — no canonical attribution shown | $15.42 | 22.4% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $68.90 | 3 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| WAKIX Normalized: wakix |
Drug | HARMONY BIOSCIENCES LLC | $31.12 | 1 | 2025 |
Source payment records
|
|||||
| REXULTI Normalized: rexulti |
Drug | Otsuka America Pharmaceutical, Inc. | $15.42 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
| Open Payments product | Payment year | Part D brand | Part D year | Claims | Match method | Source |
|---|---|---|---|---|---|---|
| REXULTI rexulti |
2025 | Rexulti | 2024 | 44 Beneficiary count suppressed |
exact normalized | Medicare Part D |
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
| Paying company | Payment year | Drug reported by same entity | Open Payments evidence | Part D | Claims | Beneficiaries |
|---|---|---|---|---|---|---|
| AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference |
2025 | BRILINTA open payments reported associated product |
CMS Open Payments — General Payments 993 supporting records · 512 recipient NPIs · example record 1206131430 |
Brilinta · 2024 Exact normalized brand match · 1 Part D row |
43 | suppressed by CMS |
| AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference |
2025 | FARXIGA open payments reported associated product |
CMS Open Payments — General Payments 106133 supporting records · 42906 recipient NPIs · example record 1206131362 |
Farxiga · 2024 Exact normalized brand match · 1 Part D row |
126 | 11 |
| AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference |
2025 | LOKELMA open payments reported associated product |
CMS Open Payments — General Payments 6897 supporting records · 4326 recipient NPIs · example record 1206131624 |
Lokelma · 2024 Exact normalized brand match · 1 Part D row |
29 | suppressed by CMS |
| AstraZeneca Pharmaceuticals LP Exact reporting entity; no affiliate inference |
2025 | SYMBICORT open payments reported associated product |
CMS Open Payments — General Payments 71 supporting records · 51 recipient NPIs · example record 1206132610 |
Symbicort · 2024 Exact normalized brand match · 1 Part D row |
15 | suppressed by CMS |
| Otsuka America Pharmaceutical, Inc. Exact reporting entity; no affiliate inference |
2025 | NUEDEXTA open payments reported associated product |
CMS Open Payments — General Payments 393 supporting records · 285 recipient NPIs · example record 1227268901 |
Nuedexta · 2024 Exact normalized brand match · 1 Part D row |
28 | suppressed by CMS |
| Otsuka America Pharmaceutical, Inc. Exact reporting entity; no affiliate inference |
2025 | REXULTI open payments reported associated product |
CMS Open Payments — General Payments 160756 supporting records · 46288 recipient NPIs · example record 1227267708 |
Rexulti · 2024 Exact normalized brand match · 1 Part D row |
44 | suppressed by CMS |
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 2101 | 327 |
| Eliquis | Apixaban | 1969 | 194 |
| Levothyroxine Sodium | Levothyroxine Sodium | 1803 | 193 |
| Trazodone Hcl | Trazodone Hcl | 1625 | 234 |
| Gabapentin | Gabapentin | 1590 | 198 |
| Furosemide | Furosemide | 1530 | 207 |
| Escitalopram Oxalate | Escitalopram Oxalate | 1285 | 149 |
| Metoprolol Succinate | Metoprolol Succinate | 1283 | 157 |
| Mirtazapine | Mirtazapine | 1205 | 146 |
| Amlodipine Besylate | Amlodipine Besylate | 1148 | 166 |
| Tamsulosin Hcl | Tamsulosin Hcl | 1040 | 130 |
| Pantoprazole Sodium | Pantoprazole Sodium | 989 | 166 |
| Potassium Chloride | Potassium Chloride | 868 | 117 |
| Memantine Hcl | Memantine Hcl | 793 | 106 |
| Metoprolol Tartrate | Metoprolol Tartrate | 772 | 127 |
| Xarelto | Rivaroxaban | 737 | 56 |
| Lisinopril | Lisinopril | 692 | 100 |
| Losartan Potassium | Losartan Potassium | 683 | 104 |
| Metformin Hcl | Metformin Hcl | 639 | 85 |
| Sertraline Hcl | Sertraline Hcl | 633 | 86 |
| Torsemide | Torsemide | 583 | 79 |
| Omeprazole | Omeprazole | 524 | 111 |
| Duloxetine Hcl | Duloxetine Hcl | 506 | 85 |
| Quetiapine Fumarate | Quetiapine Fumarate | 477 | 61 |
| Donepezil Hcl | Donepezil Hcl | 452 | 56 |
| Methenamine Hippurate | Methenamine Hippurate | 442 | 32 |
| Buspirone Hcl | Buspirone Hcl | 438 | 50 |
| Jardiance | Empagliflozin | 434 | 47 |
| Lactulose | Lactulose | 434 | 60 |
| Divalproex Sodium | Divalproex Sodium | 423 | 59 |
| Clopidogrel | Clopidogrel Bisulfate | 418 | 46 |
| Allopurinol | Allopurinol | 405 | 51 |
| Levetiracetam | Levetiracetam | 388 | 49 |
| Risperidone | Risperidone | 383 | 32 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 369 | 37 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 367 | 56 |
| Prednisone | Prednisone | 365 | 77 |
| Januvia | Sitagliptin Phosphate | 359 | 33 |
| Finasteride | Finasteride | 301 | 47 |
| Bupropion Xl | Bupropion Hcl | 300 | 36 |
| Simvastatin | Simvastatin | 297 | 34 |
| Midodrine Hcl | Midodrine Hcl | 279 | 34 |
| Fluoxetine Hcl | Fluoxetine Hcl | 278 | 23 |
| Warfarin Sodium | Warfarin Sodium | 274 | 14 |
| Carvedilol | Carvedilol | 273 | 59 |
| Baclofen | Baclofen | 261 | 39 |
| Myrbetriq | Mirabegron | 257 | 25 |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 244 | 123 |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 231 | 48 |
| Ondansetron Hcl | Ondansetron Hcl | 212 | 91 |
| Citalopram Hbr | Citalopram Hydrobromide | 206 | 30 |
| Hydralazine Hcl | Hydralazine Hcl | 205 | 25 |
| Famotidine | Famotidine | 201 | 32 |
| Spironolactone | Spironolactone | 201 | 33 |
| Lamotrigine | Lamotrigine | 192 | 30 |
| Tradjenta | Linagliptin | 192 | 13 |
| Diltiazem 24hr Er (La) | Diltiazem Hcl | 189 | suppressed |
| Aripiprazole | Aripiprazole | 188 | 15 |
| Diclofenac Sodium | Diclofenac Sodium | 181 | 61 |
| Latanoprost | Latanoprost | 181 | 45 |
| Pravastatin Sodium | Pravastatin Sodium | 179 | 24 |
| Diltiazem 24hr Er (Cd) | Diltiazem Hcl | 175 | 16 |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 173 | 21 |
| Gemtesa | Vibegron | 172 | 17 |
| Montelukast Sodium | Montelukast Sodium | 167 | 23 |
| Olanzapine | Olanzapine | 163 | 24 |
| Paroxetine Hcl | Paroxetine Hcl | 158 | 17 |
| Ezetimibe | Ezetimibe | 147 | 29 |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 145 | 20 |
| Doxycycline Hyclate | Doxycycline Hyclate | 141 | 67 |
| Metoclopramide Hcl | Metoclopramide Hcl | 141 | 22 |
| Amiodarone Hcl | Amiodarone Hcl | 138 | 30 |
| Lantus | Insulin Glargine,hum.Rec.Anlog | 136 | 22 |
| Methocarbamol | Methocarbamol | 136 | 45 |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 131 | 46 |
| Meloxicam | Meloxicam | 129 | 25 |
| Ropinirole Hcl | Ropinirole Hcl | 129 | 21 |
| Trulicity | Dulaglutide | 128 | 18 |
| Farxiga | Dapagliflozin Propanediol | 126 | 11 |
| Hydrochlorothiazide | Hydrochlorothiazide | 125 | 23 |
| Fluticasone Propionate | Fluticasone Propionate | 124 | 52 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 122 | 26 |
| Alendronate Sodium | Alendronate Sodium | 118 | 25 |
| Linzess | Linaclotide | 118 | 22 |
| Memantine Hcl Er | Memantine Hcl | 115 | suppressed |
| Bumetanide | Bumetanide | 114 | 19 |
| Benztropine Mesylate | Benztropine Mesylate | 108 | suppressed |
| Clozapine | Clozapine | 107 | suppressed |
| Albuterol Sulfate | Albuterol Sulfate | 105 | 19 |
| Entresto | Sacubitril/Valsartan | 105 | 16 |
| Insulin Lispro | Insulin Lispro | 105 | 25 |
| Carbidopa-Levodopa Er | Carbidopa/Levodopa | 104 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 103 | 55 |
| Oxybutynin Chloride | Oxybutynin Chloride | 102 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 101 | 22 |
| Topiramate | Topiramate | 98 | 13 |
| Nuplazid | Pimavanserin Tartrate | 96 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 95 | 11 |
| Breo Ellipta | Fluticasone/Vilanterol | 93 | 17 |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 93 | 37 |
| Nystatin | Nystatin | 93 | 42 |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 86 | 18 |
| Digoxin | Digoxin | 79 | 16 |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 79 | 20 |
| Mupirocin | Mupirocin | 78 | 56 |
| Quetiapine Fumarate Er | Quetiapine Fumarate | 78 | suppressed |
| Dicyclomine Hcl | Dicyclomine Hcl | 77 | suppressed |
| Enulose | Lactulose | 76 | 14 |
| Lubiprostone | Lubiprostone | 75 | suppressed |
| Xifaxan | Rifaximin | 75 | suppressed |
| Fludrocortisone Acetate | Fludrocortisone Acetate | 72 | suppressed |
| Glipizide | Glipizide | 72 | suppressed |
| Janumet | Sitagliptin Phos/Metformin Hcl | 70 | suppressed |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 70 | 39 |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 69 | suppressed |
| Prazosin Hcl | Prazosin Hcl | 69 | suppressed |
| Fluticasone-Salmeterol | Fluticasone Propion/Salmeterol | 67 | 17 |
| Nifedipine Er | Nifedipine | 66 | suppressed |
| Oseltamivir Phosphate | Oseltamivir Phosphate | 66 | 55 |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 66 | 41 |
| Atenolol | Atenolol | 65 | 17 |
| Ozempic | Semaglutide | 65 | 15 |
| Sodium Chloride | 0.9 % Sodium Chloride | 65 | 39 |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 64 | suppressed |
| Sevelamer Carbonate | Sevelamer Carbonate | 64 | 11 |
| Silodosin | Silodosin | 64 | 12 |
| Carbamazepine | Carbamazepine | 63 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 63 | 15 |
| Namzaric | Memantine Hcl/Donepezil Hcl | 63 | suppressed |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 62 | 46 |
| Irbesartan | Irbesartan | 62 | suppressed |
| Anastrozole | Anastrozole | 61 | suppressed |
| Metronidazole | Metronidazole | 61 | suppressed |
| Rytary | Carbidopa/Levodopa | 60 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 59 | 18 |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 58 | suppressed |
| Humalog | Insulin Lispro | 58 | 16 |
| Lovastatin | Lovastatin | 58 | suppressed |
| Amoxicillin-Clavulanate Potass | Amoxicillin/Potassium Clav | 57 | 43 |
| Perphenazine | Perphenazine | 57 | suppressed |
| Entacapone | Entacapone | 55 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 53 | 17 |
| Bupropion Hcl Sr | Bupropion Hcl | 52 | suppressed |
| Cephalexin | Cephalexin | 52 | 37 |
| Enoxaparin Sodium | Enoxaparin Sodium | 52 | 18 |
| Ketoconazole | Ketoconazole | 52 | 31 |
| Rivastigmine | Rivastigmine Tartrate | 52 | suppressed |
| Trihexyphenidyl Hcl | Trihexyphenidyl Hcl | 52 | suppressed |
| Desvenlafaxine Succinate Er | Desvenlafaxine Succinate | 50 | suppressed |
| Ranolazine Er | Ranolazine | 50 | suppressed |
| Sucralfate | Sucralfate | 48 | 15 |
| Brimonidine Tartrate | Brimonidine Tartrate | 47 | suppressed |
| Paliperidone Er | Paliperidone | 47 | suppressed |
| Restasis | Cyclosporine | 47 | 12 |
| Tizanidine Hcl | Tizanidine Hcl | 47 | suppressed |
| Ceftriaxone | Ceftriaxone Sodium | 46 | 28 |
| Levemir | Insulin Detemir | 46 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 46 | suppressed |
| Tolterodine Tartrate Er | Tolterodine Tartrate | 46 | suppressed |
| Levofloxacin | Levofloxacin | 45 | 32 |
| Rexulti | Brexpiprazole | 44 | suppressed |
| Brilinta | Ticagrelor | 43 | suppressed |
| Budesonide | Budesonide | 43 | 12 |
| Incruse Ellipta | Umeclidinium Bromide | 43 | suppressed |
| Lidocaine | Lidocaine | 43 | suppressed |
| Brimonidine Tartrate-Timolol | Brimonidine Tartrate/Timolol | 42 | suppressed |
| Fenofibrate | Fenofibrate Nanocrystallized | 41 | suppressed |
| Methimazole | Methimazole | 41 | suppressed |
| Calcitriol | Calcitriol | 40 | suppressed |
| Oxcarbazepine | Oxcarbazepine | 40 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 39 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 39 | 28 |
| Clotrimazole-Betamethasone | Clotrimazole/Betamethasone Dip | 39 | 17 |
| Glimepiride | Glimepiride | 39 | suppressed |
| Timolol Maleate | Timolol Maleate | 39 | suppressed |
| Dorzolamide-Timolol | Dorzolamide Hcl/Timolol Maleat | 38 | suppressed |
| Scopolamine | Scopolamine | 38 | 13 |
| Amitriptyline Hcl | Amitriptyline Hcl | 37 | suppressed |
| Dorzolamide Hcl | Dorzolamide Hcl | 37 | 11 |
| Lumigan | Bimatoprost | 37 | suppressed |
| Nitroglycerin Patch | Nitroglycerin | 37 | suppressed |
| Liothyronine Sodium | Liothyronine Sodium | 36 | suppressed |
| Spiriva Handihaler | Tiotropium Bromide | 36 | suppressed |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 36 | suppressed |
| Chlorhexidine Gluconate | Chlorhexidine Gluconate | 35 | 17 |
| Flecainide Acetate | Flecainide Acetate | 35 | suppressed |
| Hydrocortisone | Hydrocortisone | 35 | 23 |
| Kapspargo Sprinkle | Metoprolol Succinate | 35 | suppressed |
| Lidocaine Hcl | Lidocaine Hcl | 35 | 28 |
| Nyamyc | Nystatin | 35 | 21 |
| Vilazodone Hcl | Vilazodone Hcl | 35 | suppressed |
| Atropine Sulfate | Atropine Sulfate | 34 | 14 |
| Fenofibrate | Fenofibrate | 34 | suppressed |
| Fiasp Flextouch | Insulin Aspart (Niacinamide) | 34 | suppressed |
| Labetalol Hcl | Labetalol Hcl | 33 | suppressed |
| Insulin Aspart | Insulin Aspart | 32 | suppressed |
| Vascepa | Icosapent Ethyl | 32 | suppressed |
| Cyclosporine | Cyclosporine | 31 | suppressed |
| Azithromycin | Azithromycin | 30 | 15 |
| Novolog Flexpen | Insulin Aspart | 30 | suppressed |
| Dapagliflozin | Dapagliflozin Propanediol | 29 | suppressed |
| Doxycycline Monohydrate | Doxycycline Monohydrate | 29 | 17 |
| Lokelma | Sodium Zirconium Cyclosilicate | 29 | suppressed |
| Lorazepam | Lorazepam | 29 | 14 |
| Retacrit | Epoetin Alfa-Epbx | 29 | suppressed |
| Spiriva Respimat | Tiotropium Bromide | 29 | suppressed |
| Dalfampridine Er | Dalfampridine | 28 | suppressed |
| Nuedexta | Dextromethorphan Hbr/Quinidine | 28 | suppressed |
| Fluticasone-Vilanterol | Fluticasone/Vilanterol | 27 | 13 |
| Prednisolone Acetate | Prednisolone Acetate | 27 | suppressed |
| Roflumilast | Roflumilast | 27 | suppressed |
| Metformin Hcl Er | Metformin Hcl | 26 | 11 |
| Methotrexate | Methotrexate Sodium | 26 | suppressed |
| Minoxidil | Minoxidil | 26 | suppressed |
| Movantik | Naloxegol Oxalate | 26 | suppressed |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 26 | suppressed |
| Ventolin Hfa | Albuterol Sulfate | 26 | 16 |
| Acetic Acid | Acetic Acid | 25 | suppressed |
| Anoro Ellipta | Umeclidinium Brm/Vilanterol Tr | 25 | suppressed |
| Cyproheptadine Hcl | Cyproheptadine Hcl | 25 | suppressed |
| Elmiron | Pentosan Polysulfate Sodium | 25 | suppressed |
| Erythromycin | Erythromycin Base | 25 | 12 |
| Metolazone | Metolazone | 25 | suppressed |
| Sotalol | Sotalol Hcl | 25 | suppressed |
| Arexvy | Rsvpref3 Antigen/As01e/Pf | 24 | 23 |
| Febuxostat | Febuxostat | 24 | suppressed |
| Vancomycin Hcl | Vancomycin Hcl | 24 | suppressed |
| Wixela Inhub | Fluticasone Propion/Salmeterol | 24 | suppressed |
| Glucagon Emergency Kit | Glucagon | 23 | suppressed |
| Nystatin-Triamcinolone | Nystatin/Triamcinolone Acet | 23 | suppressed |
| Ongentys | Opicapone | 23 | suppressed |
| Xadago | Safinamide Mesylate | 23 | suppressed |
| Dilantin | Phenytoin Sodium Extended | 22 | suppressed |
| Pramipexole Dihydrochloride | Pramipexole Di-Hcl | 22 | suppressed |
| Tramadol Hcl | Tramadol Hcl | 22 | suppressed |
| Triamterene-Hydrochlorothiazid | Triamterene/Hydrochlorothiazid | 22 | suppressed |
| Alogliptin | Alogliptin Benzoate | 21 | suppressed |
| Bupropion Hcl | Bupropion Hcl | 21 | suppressed |
| Colchicine | Colchicine | 21 | suppressed |
| Combivent Respimat | Ipratropium/Albuterol Sulfate | 21 | suppressed |
| Diltiazem Hcl | Diltiazem Hcl | 21 | suppressed |
| Doxazosin Mesylate | Doxazosin Mesylate | 21 | suppressed |
| Folic Acid | Folic Acid | 21 | suppressed |
| Klor-Con 10 | Potassium Chloride | 21 | suppressed |
| Lyumjev Kwikpen U-100 | Insulin Lispro-Aabc | 21 | suppressed |
| Tiotropium Bromide | Tiotropium Bromide | 21 | suppressed |
| Amoxicillin | Amoxicillin | 20 | 13 |
| Carbamazepine Er | Carbamazepine | 20 | suppressed |
| Cyclobenzaprine Hcl | Cyclobenzaprine Hcl | 20 | 16 |
| Santyl | Collagenase Clostridium Hist. | 20 | 17 |
| Clindamycin Hcl | Clindamycin Hcl | 19 | 15 |
| Estradiol | Estradiol | 19 | suppressed |
| Ingrezza | Valbenazine Tosylate | 19 | suppressed |
| Lithium Carbonate | Lithium Carbonate | 19 | suppressed |
| Mirabegron Er | Mirabegron | 19 | 11 |
| Primidone | Primidone | 19 | suppressed |
| Tresiba Flextouch U-100 | Insulin Degludec | 19 | suppressed |
| Ursodiol | Ursodiol | 19 | suppressed |
| Abrysvo | Rsv Vacc, Pref A And Pref B/Pf | 18 | 18 |
| Enalapril Maleate | Enalapril Maleate | 18 | suppressed |
| Haloperidol | Haloperidol | 18 | suppressed |
| Lagevrio (Eua) | Molnupiravir | 18 | 18 |
| Rivastigmine | Rivastigmine | 18 | suppressed |
| Trimethoprim | Trimethoprim | 18 | suppressed |
| Eplerenone | Eplerenone | 17 | suppressed |
| Pulmicort Flexhaler | Budesonide | 17 | suppressed |
| Budesonide Er | Budesonide | 16 | suppressed |
| Invokana | Canagliflozin | 16 | suppressed |
| Ramelteon | Ramelteon | 16 | suppressed |
| Trintellix | Vortioxetine Hydrobromide | 16 | suppressed |
| Venlafaxine Hcl | Venlafaxine Hcl | 16 | suppressed |
| Cholestyramine | Cholestyramine (With Sugar) | 15 | suppressed |
| Diazepam | Diazepam | 15 | suppressed |
| Fluconazole | Fluconazole | 15 | 12 |
| Novolog | Insulin Aspart | 15 | suppressed |
| Procrit | Epoetin Alfa | 15 | suppressed |
| Solifenacin Succinate | Solifenacin Succinate | 15 | suppressed |
| Symbicort | Budesonide/Formoterol Fumarate | 15 | suppressed |
| Tresiba Flextouch U-200 | Insulin Degludec | 15 | suppressed |
| Bethanechol Chloride | Bethanechol Chloride | 14 | suppressed |
| Clomipramine Hcl | Clomipramine Hcl | 14 | suppressed |
| Diltiazem 24hr Er (Xr) | Diltiazem Hcl | 14 | suppressed |
| Fluvoxamine Maleate | Fluvoxamine Maleate | 14 | suppressed |
| Gentamicin Sulfate | Gentamicin Sulfate | 14 | suppressed |
| Ibuprofen | Ibuprofen | 14 | suppressed |
| Nitroglycerin | Nitroglycerin | 14 | 14 |
| Singulair | Montelukast Sodium | 14 | suppressed |
| Terazosin Hcl | Terazosin Hcl | 14 | suppressed |
| Dorzolamide-Timolol | Dorzolamide/Timolol/Pf | 13 | suppressed |
| Ertapenem | Ertapenem Sodium | 13 | suppressed |
| Mycophenolate Mofetil | Mycophenolate Mofetil | 13 | suppressed |
| Pregabalin | Pregabalin | 13 | suppressed |
| Veltassa | Patiromer Calcium Sorbitex | 13 | suppressed |
| Verapamil Er | Verapamil Hcl | 13 | suppressed |
| Verapamil Hcl | Verapamil Hcl | 13 | suppressed |
| Vyzulta | Latanoprostene Bunod | 13 | suppressed |
| Calcitonin-Salmon | Calcitonin,salmon,synthetic | 12 | suppressed |
| Cefpodoxime Proxetil | Cefpodoxime Proxetil | 12 | suppressed |
| Dextrose 5%-0.45% Nacl | Dextrose 5 %-0.45 % Sod Chlord | 12 | suppressed |
| Doxepin Hcl | Doxepin Hcl | 12 | suppressed |
| Fluticasone Propionate Hfa | Fluticasone Propionate | 12 | suppressed |
| Galantamine Er | Galantamine Hbr | 12 | suppressed |
| Ondansetron Odt | Ondansetron | 12 | 11 |
| Pentoxifylline | Pentoxifylline | 12 | suppressed |
| Pred Mild | Prednisolone Acetate | 12 | suppressed |
| Protonix | Pantoprazole Sodium | 12 | suppressed |
| Rhopressa | Netarsudil Mesylate | 12 | suppressed |
| Sps | Sodium Polystyrene Sulfon/Sorb | 12 | suppressed |
| Valacyclovir | Valacyclovir Hcl | 12 | suppressed |
| Valproic Acid | Valproic Acid (As Sodium Salt) | 12 | suppressed |
| Acetazolamide | Acetazolamide | 11 | suppressed |
| Combigan | Brimonidine Tartrate/Timolol | 11 | suppressed |
| Dexamethasone | Dexamethasone | 11 | suppressed |
| Glycopyrrolate | Glycopyrrolate | 11 | suppressed |
| Ketorolac Tromethamine | Ketorolac Tromethamine | 11 | suppressed |
| Kionex | Sodium Polystyrene Sulfon/Sorb | 11 | suppressed |
| Leflunomide | Leflunomide | 11 | suppressed |
| Propylthiouracil | Propylthiouracil | 11 | suppressed |
| Raloxifene Hcl | Raloxifene Hcl | 11 | suppressed |
| Rocklatan | Netarsudil Mesylat/Latanoprost | 11 | suppressed |
| Simbrinza | Brinzolamide/Brimonidine Tart | 11 | suppressed |
| Sumatriptan Succinate | Sumatriptan Succinate | 11 | suppressed |
| Xiidra | Lifitegrast | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $68.90 · 3 records | HARMONY BIOSCIENCES LLC | REXULTI, WAKIX | 6 | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- What role, if any, does Rexulti play in your treatment recommendations for me?
- How do you evaluate evidence when you have a financial relationship with AstraZeneca Pharmaceuticals LP?
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error